The Broader Lessons of the EpiPen Debacle
The firestorm of controversy surrounding the epinephrine auto-injector’s rising prices raises additional issues about the U.S. pharma market.
October 07, 2016 7:00 AM
James R. Baker Jr., M.D.
James R. Baker Jr., M.D., is CEO of Food Allergy Research & Education (FARE) and the Ruth Dow Doan Professor at the University of Michigan.
More Authors
Jordyn Imhoff
Public Relations Representative
